Lifearc

United Kingdom


Create a watch for Lifearc
Total IP 43
Total IP Rank # 33,253
IP Activity Score 2.4/5.0    29
IP Activity Rank # 26,652
Dominant Nice Class Advertising and business services

Patents

Trademarks

16 2
7 0
16 3
0
 
Last Patent 2025 - Dna-pk inhibitor compounds and u...
First Patent 2010 - Compounds
Last Trademark 2024 - LIFEARC
First Trademark 2017 - LIFEARC

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Downloadable electronic educational and professional publications; downloadable electronic educat...
G/S Downloadable electronic educational and professional publications; downloadable electronic educa...
2023 G/S Promoting research in the field of human health and human diseases through the support and coord...
Invention Dna-pk inhibitor compounds and uses thereof. Provided are compounds and method for inhibiting DN...
Invention Dna-pk inhibitor compounds and uses thereof. Provided are compounds and method for inhibiting DNA...
2022 Invention Galanin-2 receptor agonists. The invention related to a chimeric protein comprising (i) a galanin...
Invention Anti-plexin-b1 antibodies. The invention relates to antibodies and antigen binding fragments ther...
Invention Ulk1/2 inhibitors and their use thereof. Described herein are compounds that are ULK1/2 inhibito...
Invention 2,4-diaminopyrimidine derivatives as ulk1/2 inhibitors and their use thereof. Described herein ar...
Invention 7-morpholino-l,6-naphthyridin-5-yl derivatives and pharmaceutical compositions thereof useful as ...
Invention 7-morpholino-1,6-naphthyridin-5-yl derivatives and pharmaceutical compositions thereof useful as ...
2021 Invention Cyclic peptides. The present invention relates to cyclized peptides based on amino acids 1-14 of...
Invention Cyclic peptides. The present invention relates to cyclized peptides based on amino acids 1-14 of ...
2020 Invention Anti-transglutaminase 2 antibodies. The invention provides antibodies and antigen-binding fragmen...
Invention Fused thiazolopyrimidine derivatives as mnks inhibitors. The present invention relates to compoun...
2019 Invention Humanised anti-il17br antibody. This invention relates to humanised versions of the murine anti-I...
Invention Humanised anti-n-truncated amyloid β monoclonal antibody. The present invention relates to humani...
Invention Humanised anti-n-truncated amyloid beta monoclonal antibody. The present invention relates to hum...
Invention Composition for treating one or more estrogen related diseases. The present invention relates to ...
Invention A composition for treating one or more estrogen related diseases. A composition for treating one ...
2017 Invention Oxazole derivatives for use in the treatment of cancer. 13) p. Said compounds are capable of inhi...
Invention Oxazole derivatives for use in the treatment of cancer. 12)p CO. Said compounds are capable of in...
Invention Oxazole derivatives for use in the treatment of cancer. A first aspect of the invention relates t...
Invention Substituted tricyclic heterocyclic compounds and use thereof. Provided are a substituted tricycli...
Invention Substituted tricyclic herteocyclic compounds and use thereof. Provided are a substituted tricycli...
Invention Humanized antibodies against enterovirus 71. The present invention provides humanized antibodies...
Invention Humanized antibodies against enterovirus 71. The present invention provides humanized antibodies ...
G/S Promoting research in the field of human health and human diseases through the support and coordi...
G/S Downloadable electronic educational and professional publications, namely, newsletters, fact she...
Invention Compounds. A compound of formula I, or a pharmaceutically acceptable salt or ester thereof, A ...
2016 Invention Pyrropyrimidine compounds as mnks inhibitors. The present invention relates to compounds of formu...